Advertisement

Citation tools

Kim, Dong-Wook et al "Efficacy and Safety of Ponatinib According to Prior Approved Tyrosine Kinase Inhibitor (TKI) Therapy in Patients with Chronic Myeloid Leukemia in Chronic Phase (CP-CML): Results From the PACE Trial." Blood 120.21 (2012): 3749. Web. 24 June. 2019.